
Please try another search
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection. It has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. The company was incorporated in 2010 and is based in Chassieu, France.
Name | Age | Since | Title |
---|---|---|---|
Jean-Luc Souche | - | 2019 | Business Developer of Biocontrôle & Director |
Valerie Filiatre | 63 | 2017 | Director |
Benoit Villers | 68 | 2023 | Chairman of the Board of Directors |
Patrice Selles | 54 | 2024 | Independent Director |
Quentin Hua | 38 | 2024 | Independent Director |
Jean-Marc Petat | 61 | 2024 | Independent Director |
Charlottes Franceries | - | 2025 | Director |
Valérie Lorentz-Poinsot | 56 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review